A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
Clinical trial NCT01248455 · TERMINATED
Trial details
- NCT number
- NCT01248455
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2014-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.